January 2020
64 articles-
Jan 31 · 09:17Biotechnology Daily
Edwards study shows TAVR outcomes similar to surgery after 5 years, but with more patient management
-
Jan 31 · 09:15Biotechnology Daily
Roche dumps antisense hep B drug after bagging rival asset
-
Jan 31 · 09:13Biotechnology Daily
More than half of clinical trials still hidden from public view: report
-
Jan 31 · 09:11Biotechnology Daily
Spring Bank scraps hep B program after patient death, 'unexpected' side effects
-
Jan 31 · 09:08Bio Business News
Sanofi's rare disease drug hits endpoint, teeing up 2021 filing
-
Jan 31 · 09:05Bio Business News
Ex-Shire/Takeda clinical trials chief Ivarsson lands at Moderna
-
Jan 31 · 09:03Bio Business News
Microsoft launches 5-year, $40M AI initiative in global health
-
Jan 31 · 09:01Bio Business News
Mammoth Biosciences nabs $45M for CRISPR drugs, diagnostics work
-
Jan 30 · 09:45Biotechnology Daily
MIT researchers develop beating 'biorobotic hybrid' for testing heart valves
-
Jan 30 · 09:39Biotechnology Daily
Profusa's wireless, injectable oxygen biosensor nabs CE mark
-
Jan 30 · 09:37Biotechnology Daily
FDA clears Eko's digital stethoscope AI for spotting cases of afib, heart murmur
-
Jan 30 · 09:33Bio Business News
After NASH flops, Conatus becomes Histogen via reverse merger
-
Jan 30 · 09:30Bio Business News
Rare disease biotech Passage Bio nabs Deerfield veteran as CEO
-
Jan 30 · 09:28Bio Business News
Laurence Reid returns to biotech as he takes up Decibel CEO role
-
Jan 30 · 09:25Bio Business News
Racing Blueprint, Lilly drug gets priority review for RET hopeful
-
Jan 29 · 08:14Biotechnology Daily
Gene That Halts Tissue Growth Identified By Scientists
-
Jan 29 · 08:13Biotechnology Daily
Never-Seen-Before Viruses Found Locked In Tibetan Glacier
-
Jan 29 · 08:12Biotechnology Daily
Life after Novartis: Jimenez joins board of Bayer-backed cell therapy startup
-
Jan 29 · 08:10Biotechnology Daily
Tracking not just data, but individual symptoms: BioIntelliSense exits stealth with FDA-cleared wearable
-
Jan 29 · 08:08Bio Business News
Pfizer cans early-stage trials for cancer, sickle cell targets
-
Jan 29 · 08:07Bio Business News
Adrangi mounts short attack on 'worthless' drugs of Sanofi ally
-
Jan 29 · 08:07Bio Business News
Philips to drop its home appliances unit in healthcare pursuit, with a new head of connected care
-
Jan 29 · 08:06Bio Business News
Akcea, Pfizer hit midphase goal, but data raise doubts about chances in NAFLD, diabetes
-
Jan 28 · 08:26Biotechnology Daily
Acceleron's PAH drug sotatercept hits the mark in phase 2